Form 4: AIM ImmunoTech Director Acquires and Disposes of Shares in Recent Transaction
SEC Form 4 Filing
Director Stewart Appelrouth reports acquiring and disposing of AIM ImmunoTech Inc. shares on March 15, 2024.
Summary
- On March 15, 2024, Stewart Appelrouth, a director of AIM ImmunoTech Inc., engaged in a transaction involving the company's common stock.
- Appelrouth acquired 90,910 shares at a price of $0.33 per share.
- Following the reported transaction, Appelrouth directly owns 239,765 shares of AIM ImmunoTech Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a director's stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The transaction may have a minor impact on shareholder sentiment, depending on how the market interprets the director's buying and selling activity.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of transaction: acquisition and disposal of common stock. |
| 03/18/2024 | Date of signature for the SEC Form 4 filing. |
Keywords
AIM ImmunoTech Inc., Stewart Appelrouth, Director, Share Transaction, Beneficial Ownership, Common Stock, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.